
Atossa Therapeutics ATOS
$ 5.4
1.31%
Quarterly report 2025-Q3
added 11-12-2025
Atossa Therapeutics P/CF Ratio 2011-2026 | ATOS
Annual P/CF Ratio Atossa Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -4.15 | -9.73 | -1.94 | -1.34 | -0.6 | -0.958 | -0.588 | -0.525 | -2.58 | -4.25 | -14.5 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.525 | -14.5 | -4.44 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Assembly Biosciences
ASMB
|
-7.51 | $ 28.49 | 0.11 % | $ 319 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 19.61 | 0.59 % | $ 917 M | ||
|
Amarin Corporation plc
AMRN
|
862 | $ 14.72 | 1.59 % | $ 6.11 B | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 221.08 | -0.36 % | $ 5 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.4 | 1.82 % | $ 357 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Axsome Therapeutics
AXSM
|
-92.9 | $ 155.38 | -0.98 % | $ 7.73 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
BioMarin Pharmaceutical
BMRN
|
14.1 | $ 55.05 | 1.7 % | $ 10.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
AbCellera Biologics
ABCL
|
-7.33 | $ 3.46 | 1.76 % | $ 1.03 B | ||
|
Benitec Biopharma
BNTC
|
-23.6 | $ 10.92 | -0.55 % | $ 449 M | ||
|
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Calithera Biosciences
CALA
|
-14.5 | - | -10.95 % | $ 876 K | ||
|
Cara Therapeutics
CARA
|
-0.588 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
-0.024 | - | - | $ 3.74 B | ||
|
Heron Therapeutics
HRTX
|
-7.19 | $ 0.79 | 2.02 % | $ 132 M | ||
|
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | ||
|
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
-1.18 | - | -7.23 % | $ 13 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Compugen Ltd.
CGEN
|
6.2 | $ 2.13 | 2.15 % | $ 199 M | ||
|
Coherus BioSciences
CHRS
|
-1.63 | $ 1.58 | 3.62 % | $ 185 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-5.18 | $ 4.47 | 5.54 % | $ 742 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-0.698 | - | -5.98 % | $ 34.1 M | ||
|
Decibel Therapeutics
DBTX
|
-1.79 | - | - | $ 123 M |